ALPKF Quote, Financials, Valuation and Earnings

CEMEX SAB de CV has a net margin of -2.17% compared to Alpek SAB de CV's net margin of 5.65%. Alpek SAB de CV's return on equity of -6.92% beat CEMEX SAB de CV's return on equity of 7.17%.

Alpek SAB de CV has a consensus price target of --, signalling downside risk potential of --. On the other hand CEMEX SAB de CV has an analysts' consensus of $11.53 which suggests that it could fall by -0.28%. Given that CEMEX SAB de CV has higher upside potential than Alpek SAB de CV, analysts believe CEMEX SAB de CV is more attractive than Alpek SAB de CV.

Alpek SAB de CV has a beta of 0.057, which suggesting that the stock is 94.29% less volatile than S&P 500. In comparison CEMEX SAB de CV has a beta of 1.610, suggesting its more volatile than the S&P 500 by 60.969%.

Alpek SAB de CV has a quarterly dividend of $0.06 per share corresponding to a yield of 0%. CEMEX SAB de CV offers a yield of 0.76% to investors and pays a quarterly dividend of $0.02 per share. Alpek SAB de CV pays 1196.7% of its earnings as a dividend. CEMEX SAB de CV pays out 13.35% of its earnings as a dividend. CEMEX SAB de CV's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Alpek SAB de CV's is not.

Alpek SAB de CV quarterly revenues are $1.7B, which are smaller than CEMEX SAB de CV quarterly revenues of $4.3B. Alpek SAB de CV's net income of -$36.1M is lower than CEMEX SAB de CV's net income of $240.3M. Notably, Alpek SAB de CV's price-to-earnings ratio is 66.50x while CEMEX SAB de CV's PE ratio is 12.43x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Alpek SAB de CV is 0.15x versus 1.07x for CEMEX SAB de CV. Usually stocks with elevated PS ratios are considered overvalued.

GCC SAB de CV has a net margin of -2.17% compared to Alpek SAB de CV's net margin of 23.01%. Alpek SAB de CV's return on equity of -6.92% beat GCC SAB de CV's return on equity of 14.53%.

Alpek SAB de CV has a consensus price target of --, signalling downside risk potential of --. On the other hand GCC SAB de CV has an analysts' consensus of -- which suggests that it could fall by --. Given that Alpek SAB de CV has higher upside potential than GCC SAB de CV, analysts believe Alpek SAB de CV is more attractive than GCC SAB de CV.

Alpek SAB de CV has a beta of 0.057, which suggesting that the stock is 94.29% less volatile than S&P 500. In comparison GCC SAB de CV has a beta of 0.476, suggesting its less volatile than the S&P 500 by 52.369%.

Alpek SAB de CV has a quarterly dividend of $0.06 per share corresponding to a yield of 0%. GCC SAB de CV offers a yield of 1% to investors and pays a quarterly dividend of $0.09 per share. Alpek SAB de CV pays 1196.7% of its earnings as a dividend. GCC SAB de CV pays out 9.69% of its earnings as a dividend. GCC SAB de CV's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Alpek SAB de CV's is not.

Alpek SAB de CV quarterly revenues are $1.7B, which are larger than GCC SAB de CV quarterly revenues of $438.5M. Alpek SAB de CV's net income of -$36.1M is lower than GCC SAB de CV's net income of $100.9M. Notably, Alpek SAB de CV's price-to-earnings ratio is 66.50x while GCC SAB de CV's PE ratio is 10.15x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Alpek SAB de CV is 0.15x versus 2.15x for GCC SAB de CV. Usually stocks with elevated PS ratios are considered overvalued.

Grupo SIMEC SAB de CV has a net margin of -2.17% compared to Alpek SAB de CV's net margin of 6.13%. Alpek SAB de CV's return on equity of -6.92% beat Grupo SIMEC SAB de CV's return on equity of 5.94%.

Alpek SAB de CV has a consensus price target of --, signalling downside risk potential of --. On the other hand Grupo SIMEC SAB de CV has an analysts' consensus of -- which suggests that it could fall by -59.27%. Given that Grupo SIMEC SAB de CV has higher upside potential than Alpek SAB de CV, analysts believe Grupo SIMEC SAB de CV is more attractive than Alpek SAB de CV.

Alpek SAB de CV has a beta of 0.057, which suggesting that the stock is 94.29% less volatile than S&P 500. In comparison Grupo SIMEC SAB de CV has a beta of 0.345, suggesting its less volatile than the S&P 500 by 65.545%.

Alpek SAB de CV has a quarterly dividend of $0.06 per share corresponding to a yield of 0%. Grupo SIMEC SAB de CV offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Alpek SAB de CV pays 1196.7% of its earnings as a dividend. Grupo SIMEC SAB de CV pays out -- of its earnings as a dividend.

Alpek SAB de CV quarterly revenues are $1.7B, which are larger than Grupo SIMEC SAB de CV quarterly revenues of $401.8M. Alpek SAB de CV's net income of -$36.1M is lower than Grupo SIMEC SAB de CV's net income of $24.6M. Notably, Alpek SAB de CV's price-to-earnings ratio is 66.50x while Grupo SIMEC SAB de CV's PE ratio is 24.38x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Alpek SAB de CV is 0.15x versus 2.79x for Grupo SIMEC SAB de CV. Usually stocks with elevated PS ratios are considered overvalued.

Vitro SAB de CV has a net margin of -2.17% compared to Alpek SAB de CV's net margin of 47.78%. Alpek SAB de CV's return on equity of -6.92% beat Vitro SAB de CV's return on equity of 9.56%.

Alpek SAB de CV has a consensus price target of --, signalling downside risk potential of --. On the other hand Vitro SAB de CV has an analysts' consensus of -- which suggests that it could fall by --. Given that Alpek SAB de CV has higher upside potential than Vitro SAB de CV, analysts believe Alpek SAB de CV is more attractive than Vitro SAB de CV.

Alpek SAB de CV has a beta of 0.057, which suggesting that the stock is 94.29% less volatile than S&P 500. In comparison Vitro SAB de CV has a beta of -27.753, suggesting its less volatile than the S&P 500 by 2875.25%.

Alpek SAB de CV has a quarterly dividend of $0.06 per share corresponding to a yield of 0%. Vitro SAB de CV offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Alpek SAB de CV pays 1196.7% of its earnings as a dividend. Vitro SAB de CV pays out -- of its earnings as a dividend.

Alpek SAB de CV quarterly revenues are $1.7B, which are larger than Vitro SAB de CV quarterly revenues of $72.1M. Alpek SAB de CV's net income of -$36.1M is lower than Vitro SAB de CV's net income of $34.5M. Notably, Alpek SAB de CV's price-to-earnings ratio is 66.50x while Vitro SAB de CV's PE ratio is 1.11x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Alpek SAB de CV is 0.15x versus 0.25x for Vitro SAB de CV. Usually stocks with elevated PS ratios are considered overvalued.